Search results
Compare risks and benefits of common medications used for Dengue Fever. Find the most popular drugs, view ratings and user reviews.
Mar 8, 2023 · Although combinations of drugs could potentially cause adverse effects due to drug–drug interactions, it might also confer several advantages with careful use. Combination therapy could target multiple pathways to promote drug synergy, and these beneficial effects may outweigh its adverse effects.
- 10.3390/v15030705
- 2023/03
- Viruses. 2023 Mar; 15(3): 705.
People also ask
Can synergistic drug combinations be used for the treatment of dengue?
Are there antiviral agents against dengue?
Does a small compound inhibit dengue virus replication?
Nov 9, 2021 · The search for specific dengue inhibitors is expanding, and the mechanisms for evaluating the efficacy of novel drugs are currently established, allowing for expedited translation into human trials. Furthermore, in the aftermath of the only FDA-approved vaccine, Dengvaxia, a safer and more effective dengue vaccine candidate is making its way ...
- Harun Norshidah, Harun Norshidah, Ramachandran Vignesh, Ngit Shin Lai
- 10.3390/molecules26226768
- 2021
- Molecules. 2021 Nov; 26(22): 6768.
- Management of Acute Allergic Reactions
- Limitations of Vaccine Effectiveness
- Syncope
- Carcinogenesis, Mutagenesis, Impairment of Fertility
- Pregnancy
- Lactation
- Pediatric Use
- Geriatric Use
DENGVAXIA may cause hypersensitivity reactions, including anaphylaxis. Appropriate medical treatment and supervision must be available following administration of DENGVAXIA.
Vaccination with DENGVAXIA may not protect all individuals. It is recommended to continue personal protection measures against mosquito bites after vaccination.
Syncope (fainting) can occur following, or even before, vaccination with DENGVAXIA as a psychogenic response to injection with a needle. Procedures should be in place to prevent injury from falling and to manage syncopal reactions.
DENGVAXIA has not been evaluated for carcinogenic or mutagenic potential or impairment of male fertility. Exposure of female rabbits to DENGVAXIA prior to and during gestation did not impair fertility. [See Use In Specific Populations]
There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to DENGVAXIA during pregnancy. Women who receive DENGVAXIA during pregnancy are encouraged to contact directly, or have their healthcare professional contact, Sanofi Pasteur Inc. at 1-800-822-2463 (1-800-VACCINE) to enroll in or obtain information about the reg...
Human data are not available to assess the impact of DENGVAXIA on milk production, its presence in breast milk, or its effects on the breastfed child. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for DENGVAXIA and any potential adverse effects on the breastfed child from DENGVAXIA...
Safety and effectiveness of DENGVAXIA in children younger than 9 years of age have not been established.
Safety and effectiveness of DENGVAXIA in adults 65 years of age and older have not been established.
Sep 30, 2021 · More in-depth characterization of the structure of the dengue NS5 protein and mechanistic insights into how it performs its multiple functions will strengthen drug discovery efforts geared towards NS5 as a target against the dengue virus.
- Juliet O Obi, Hernando Gutiérrez-Barbosa, Joel V Chua, Daniel J Deredge
- 10.3390/tropicalmed6040180
- 2021
- Trop Med Infect Dis. 2021 Dec; 6(4): 180.
Oct 5, 2021 · In this review, the possible drug targets for discovery and development of potential antiviral drugs against structural proteins of dengue virus, the current development status of the antiviral drugs against dengue around the world, and challenges that need to be addressed to overcome the shortcomings in the process of drug discovery have been d...
Jun 6, 2022 · Rash. Intense pain behind your eyes. Nausea or vomiting. Muscle, bone and joint pain. Dengue fever symptoms start to appear four to 10 days after a mosquito bite and can last three to seven days. About 1 in 20 people sick with dengue will develop severe dengue after their initial symptoms begin to fade.
